Format

Send to

Choose Destination
See comment in PubMed Commons below
Foot Ankle Surg. 2013 Dec;19(4):212-7. doi: 10.1016/j.fas.2013.06.011. Epub 2013 Aug 28.

A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.

Author information

1
Green Templeton College, University of Oxford, Woodstock Road, Oxford OX2 6HG, United Kingdom. Electronic address: shafic2@hotmail.com.

Abstract

Acute Charcot neuroarthropathy is a devastating condition and, its incidence is increasing. Currently, treatment consists of immobilisation and off-loading of the involved extremity. Outcomes are frequently poor and novel treatments are being sought urgently. This review aims to outline advances in the pharmacological treatment of this, condition. PubMed and the Cochrane Database of systematic reviews were searched. Relevant papers were cross referenced. Eleven original studies were identified. The limited data available suggest pamidronate, alendronate and calcitonin provide some clinical and biochemical improvements while zoledronic acid is deleterious and, increases off-loading times. However, the data is not robust enough to convincingly demonstrate clinically meaningful effects. The studies were predominantly low quality and heterogeneous. They differed markedly in study type, pharmacological agent used, dosing regimen, disease, aetiology/stage/location, concurrent off-loading regimen, outcomes and, follow-up. Few were rigorous in controlling for associated confounding variables and none investigated long term outcomes. The routine use of pharmacological treatment modalities for this condition is not recommended in the United States by the Food and Drug Administration or in the United Kingdom by the National Institute for Health and Clinical Excellence. Given the evidence available this is justified and further higher quality research is required.

KEYWORDS:

Charcot; Charcot neuroarthropathy

PMID:
24095226
DOI:
10.1016/j.fas.2013.06.011
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center